133 related articles for article (PubMed ID: 10080667)
21. Analysis of the local control in lymph-node staged localized prostate cancer treated by external beam radiotherapy, assessed by digital rectal examination, serum prostate-specific antigen and biopsy.
Borghede G; Aldenborg F; Wurzinger E; Johansson KA; Hedelin H
Br J Urol; 1997 Aug; 80(2):247-55. PubMed ID: 9284197
[TBL] [Abstract][Full Text] [Related]
22. Brachytherapy in Belgium in 2018. A national survey of the brachytherapy study group of the Belgian SocieTy for Radiotherapy and Oncology (BeSTRO).
Salembier C; De Hertogh O; Daisne JF; Palumbo S; Van Gestel D
Radiother Oncol; 2020 Sep; 150():245-252. PubMed ID: 32679309
[TBL] [Abstract][Full Text] [Related]
23. Radiotherapy for head and neck cancer in Lombardy: a survey by the Lombardy Group of the Italian Association for Radiation Oncology.
Merlotti A; Di Muzio N; Antognoni P; Filippone F; Bianchi E; Castiglioni S; Bruschieri L; Ivaldi G; De Cicco L; Marzoli L; Orecchia R
Tumori; 2015; 101(5):560-5. PubMed ID: 25983103
[TBL] [Abstract][Full Text] [Related]
24. A national survey of AIRO (Italian Association of Radiation Oncology) brachytherapy (Interventional Radiotherapy) study group.
Autorino R; Vicenzi L; Tagliaferri L; Soatti C; Kovacs PG; Aristei C
J Contemp Brachytherapy; 2018 Jun; 10(3):254-259. PubMed ID: 30038646
[TBL] [Abstract][Full Text] [Related]
25. Localized carcinoma of the prostate (stages T1B, T1C, T2, and T3). Review of management with external beam radiation therapy.
Perez CA; Hanks GE; Leibel SA; Zietman AL; Fuks Z; Lee WR
Cancer; 1993 Dec; 72(11):3156-73. PubMed ID: 7694785
[TBL] [Abstract][Full Text] [Related]
26. Patterns of practice in the radiation therapy management of rectal cancer: survey of the Interregional Group Piedmont, Valle d'Aosta and Liguria of the "Associazione Italiana di Radioterapia Oncologica (AIRO)".
Di Genesio Pagliuca M; Turri L; Munoz F; Melano A; Bacigalupo A; Franzone P; Sciacero P; Tseroni V; Vitali ML; Delmastro E; Scolaro T; Marziano C; Orsatti M; Tessa M; Rossi A; Ballare A; Moro G; Grasso R; Krengli M
Tumori; 2013; 99(1):61-7. PubMed ID: 23549002
[TBL] [Abstract][Full Text] [Related]
27. [Managing patients with prostate cancer in Italy during the first year after diagnosis. A cost description based on a sample of 8 urological wards].
Lazzaro C;
Arch Ital Urol Androl; 2003 Sep; 75(3):138-49. PubMed ID: 14661392
[TBL] [Abstract][Full Text] [Related]
28. Three-dimensional conformal therapy versus standard radiation therapy in localized carcinoma of prostate: an update.
Perez CA; Michalski JM; Mansur D; Lockett MA
Clin Prostate Cancer; 2002 Sep; 1(2):97-104. PubMed ID: 15046700
[TBL] [Abstract][Full Text] [Related]
29. [18F]fluoroethylcholine-PET/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET/CT-positive lymph nodes.
Würschmidt F; Petersen C; Wahl A; Dahle J; Kretschmer M
Radiat Oncol; 2011 May; 6():44. PubMed ID: 21529377
[TBL] [Abstract][Full Text] [Related]
30. [Radiotherapy of prostatic cancer: staging and radiotherapy planning with transrectal ultrasound].
Braun J; Hofmann R; Czempiel H
Urol Int; 1985; 40(1):25-9. PubMed ID: 3883614
[TBL] [Abstract][Full Text] [Related]
31. Treatment outcomes of three-dimensional conformal radiotherapy for localized prostate carcinoma: a large community-based experience.
McCloskey SA; Ellerbroek NA; McCarthy L; Malcolm AW; Tao ML; Wollman RC; Rose CM
Cancer; 2004 Dec; 101(11):2693-700. PubMed ID: 15494974
[TBL] [Abstract][Full Text] [Related]
32. [High-dose-rate brachytherapy of prostatic carcinoma with iridium 192].
Schwarzer JU; Hofmann R; Kneschaurek P; Lukas P; Lindner A; Braun J
Strahlenther Onkol; 1992 Jan; 168(1):17-22. PubMed ID: 1734585
[TBL] [Abstract][Full Text] [Related]
33. Calculated prostate carcinoma volume: The optimal predictor of 3-year prostate specific antigen (PSA) failure free survival after surgery or radiation therapy of patients with pretreatment PSA levels of 4-20 nanograms per milliliter.
D'Amico AV; Whittington R; Kaplan I; Beard C; Schultz D; Malkowicz SB; Wein A; Tomaszewski JE; Coleman CN
Cancer; 1998 Jan; 82(2):334-41. PubMed ID: 9445191
[TBL] [Abstract][Full Text] [Related]
34. Patterns of postoperative radiotherapy for head and neck cancer in Italy: a prospective, observational study by the head and neck group of the Italian Association for Radiation Oncology (AIRO).
Palazzi M; Alterio D; Tonoli S; Caspiani O; Bolner A; Colombo S; Dall'oglio S; Lastrucci L; Bunkheila F; Cianciulli M; Vigna Taglianti R; Cante D; Merlotti A; Bianchi E; Rampino M; Podhradska A; Fontana A; Paiar F; Miccichè F; Manzo R; Ursino S; Bruschieri L; Bacigalupo A; Iannone T; Barca R; Tomatis S
Tumori; 2011; 97(2):170-6. PubMed ID: 21617711
[TBL] [Abstract][Full Text] [Related]
35. Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland: A survey on patterns of practice.
Panje CM; Dal Pra A; Zilli T; R Zwahlen D; Papachristofilou A; Herrera FG; Matzinger O; Plasswilm L; Putora PM
Strahlenther Onkol; 2015 Oct; 191(10):778-86. PubMed ID: 25986251
[TBL] [Abstract][Full Text] [Related]
36. Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.
Kupelian P; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A; Kuban D
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):795-9. PubMed ID: 15925452
[TBL] [Abstract][Full Text] [Related]
37. Non-palliative radiotherapy in ab initio oligometastatic prostate cancer: an Italian national survey.
Timon G; Jereczek-Fossa BA; Fersino S; Iotti C; Corvò R; Magrini SM; Alongi F
Radiol Med; 2019 Mar; 124(3):211-217. PubMed ID: 30361923
[TBL] [Abstract][Full Text] [Related]
38. Dose escalation in image-guided, intensity-modulated radiotherapy of carcinoma prostate: initial experience in India.
Swamy K; Sathiya Narayanan VK; Basu S; Maiya V; Achari R; Deshpande S; Bhangle J; Gupta KK; Babu N; Pawar S; Atre A; Balachandra K; Koppiker CB
J Cancer Res Ther; 2009; 5(4):277-83. PubMed ID: 20160362
[TBL] [Abstract][Full Text] [Related]
39. How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO).
Mazzeo E; Triggiani L; Frassinelli L; Guarneri A; Bartoncini S; Antognoni P; Gottardo S; Greco D; Borghesi S; Nanni S; Bruni A; Ingrosso G; D'Angelillo RM; Detti B; Francolini G; Magli A; Guerini AE; Arcangeli S; Spiazzi L; Ricardi U; Lohr F; Magrini SM
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34070797
[TBL] [Abstract][Full Text] [Related]
40. Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer.
Fiorino C; Sanguineti G; Cozzarini C; Fellin G; Foppiano F; Menegotti L; Piazzolla A; Vavassori V; Valdagni R
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):953-62. PubMed ID: 14575825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
